Medicaid Managed Care Open Enrollment Extended through Dec. 15
Current Suspected Overdose Deaths in Delaware for 2017: 225

Delaware.gov logo

DHSS Press Release



Rita Landgraf, Secretary
Jill Fredel, Director of Communications
302-255-9047, Pager 302-357-7498
Email: jill.fredel@state.de.us

Date: March 21, 2013
DHSS-33-2013





FOUR NEW CASTLE COUNTY FACILITIES IMPACTED BY MED PREP DRUG RECALL


The Delaware Division of Public Health (DPH) announced today that four New Castle County facilities were part of the Med Prep drug recall:

Med Prep Consulting Inc. of Tinton Falls, N.J. is voluntarily recalling all lots of products compounded at its facility. The recall resulted from the pharmacy being notified by a Connecticut hospital that it observed visible particulate contaminants in 50 ml bags of Magnesium Sulfate intravenous solution that were confirmed to be mold. Although administration of an intravenous product found to be contaminated with mold could result in a fatal infection, it is uncertain whether the mold found in these products can cause illness in humans. In an abundance of caution, the pharmacy included all compounded products in the voluntary recall due to lack of sterility assurance.

While the New Castle County facilities were on the list of medical providers that received the expanded recall list, no Delaware facility received Magnesium Sulfate, the drug that was observed in Connecticut to be contaminated. No known illnesses have been identified in Delaware or any other state related to the recall at this time.

DPH recommends any individuals with concerns who are patients at the four above facilities, contact that facility.



Delaware Health and Social Services is committed to improving the quality of the lives of Delaware's citizens by promoting health and well-being, fostering self-sufficiency, and protecting vulnerable populations.





+